Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free MLSS Stock Alerts

Milestone Scientific (MLSS) Competitors

Milestone Scientific logo
$0.48 +0.01 (+2.23%)
As of 08/21/2026 04:00 PM Eastern
Compare

MLSS vs. KRMD, INGN, APYX, KEQU, and MBOT

Should you buy Milestone Scientific stock or one of its competitors? Milestone Scientific's main competitors and comparable companies include KORU Medical Systems (KRMD), Inogen (INGN), Apyx Medical (APYX), Kewaunee Scientific (KEQU), and Microbot Medical (MBOT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Milestone Scientific compare to KORU Medical Systems?

Milestone Scientific (NYSE:MLSS) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Milestone Scientific has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than Milestone Scientific. KORU Medical Systems is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$9.42M4.53-$6.93M-$0.04N/A
KORU Medical Systems$41.13M3.58-$2.64M-$0.04N/A

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 107.99%. KORU Medical Systems has a consensus target price of $7.00, suggesting a potential upside of 118.07%. Given KORU Medical Systems' higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than Milestone Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, KORU Medical Systems had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 1 mentions for KORU Medical Systems and 0 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 equaled KORU Medical Systems'average media sentiment score.

Company Overall Sentiment
Milestone Scientific Neutral
KORU Medical Systems Neutral

KORU Medical Systems has a net margin of -4.03% compared to Milestone Scientific's net margin of -52.01%. KORU Medical Systems' return on equity of -10.63% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
KORU Medical Systems -4.03%-10.63%-6.51%

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

KORU Medical Systems beats Milestone Scientific on 10 of the 14 factors compared between the two stocks.

How does Milestone Scientific compare to Inogen?

Inogen (NASDAQ:INGN) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

In the previous week, Inogen had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 1 mentions for Inogen and 0 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 beat Inogen's score of -0.15 indicating that Milestone Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
Inogen Neutral
Milestone Scientific Neutral

Inogen has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Milestone Scientific has lower revenue, but higher earnings than Inogen. Milestone Scientific is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$348.67M0.43-$22.75M-$0.90N/A
Milestone Scientific$9.42M4.53-$6.93M-$0.04N/A

89.9% of Inogen shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 2.5% of Inogen shares are held by insiders. Comparatively, 9.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Milestone Scientific has a consensus target price of $1.00, indicating a potential upside of 107.99%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Inogen has a net margin of -6.94% compared to Milestone Scientific's net margin of -52.01%. Inogen's return on equity of -13.17% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-6.94% -13.17% -8.36%
Milestone Scientific -52.01%-60.26%-40.23%

Summary

Inogen beats Milestone Scientific on 9 of the 17 factors compared between the two stocks.

How does Milestone Scientific compare to Apyx Medical?

Milestone Scientific (NYSE:MLSS) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Milestone Scientific has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market.

In the previous week, Apyx Medical had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for Milestone Scientific. Apyx Medical's average media sentiment score of 1.84 beat Milestone Scientific's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Milestone Scientific Neutral
Apyx Medical Very Positive

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by insiders. Comparatively, 15.9% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Milestone Scientific presently has a consensus target price of $1.00, indicating a potential upside of 107.99%. Apyx Medical has a consensus target price of $6.60, indicating a potential upside of 111.54%. Given Apyx Medical's higher possible upside, analysts plainly believe Apyx Medical is more favorable than Milestone Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71

Apyx Medical has a net margin of -14.78% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
Apyx Medical -14.78%-76.60%-13.91%

Milestone Scientific has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$9.42M4.53-$6.93M-$0.04N/A
Apyx Medical$52.84M2.49-$11.21M-$0.20N/A

Summary

Apyx Medical beats Milestone Scientific on 11 of the 17 factors compared between the two stocks.

How does Milestone Scientific compare to Kewaunee Scientific?

Milestone Scientific (NYSE:MLSS) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Milestone Scientific currently has a consensus price target of $1.00, suggesting a potential upside of 107.99%. Given Milestone Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Milestone Scientific is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Kewaunee Scientific had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 1 mentions for Kewaunee Scientific and 0 mentions for Milestone Scientific. Kewaunee Scientific's average media sentiment score of 1.63 beat Milestone Scientific's score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
Milestone Scientific Neutral
Kewaunee Scientific Very Positive

Kewaunee Scientific has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$9.42M4.53-$6.93M-$0.04N/A
Kewaunee Scientific$282M0.38$9.62M$3.2211.51

Kewaunee Scientific has a net margin of 3.41% compared to Milestone Scientific's net margin of -52.01%. Kewaunee Scientific's return on equity of 14.10% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
Kewaunee Scientific 3.41%14.10%5.55%

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Milestone Scientific has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market.

Summary

Kewaunee Scientific beats Milestone Scientific on 11 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Milestone Scientific has higher revenue and earnings than Microbot Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$13.14M-$0.24N/A
Milestone Scientific$9.42M4.53-$6.93M-$0.04N/A

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 9.2% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Microbot Medical presently has a consensus price target of $6.38, suggesting a potential upside of 325.00%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 107.99%. Given Microbot Medical's higher probable upside, equities analysts clearly believe Microbot Medical is more favorable than Milestone Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Microbot Medical had 12 more articles in the media than Milestone Scientific. MarketBeat recorded 12 mentions for Microbot Medical and 0 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 beat Microbot Medical's score of -0.80 indicating that Milestone Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
Microbot Medical Negative
Milestone Scientific Neutral

Microbot Medical has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Microbot Medical's return on equity of -21.87% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.87% -20.76%
Milestone Scientific -52.01%-60.26%-40.23%

Summary

Microbot Medical beats Milestone Scientific on 9 of the 15 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MLSS vs. The Competition

Export
MetricMilestone ScientificHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$41.73M$6.02B$7.37B$24.30B
Dividend YieldN/A1.74%2.53%3.70%
P/E Ratio-6.8726.54272.3330.23
Price / Sales4.5371.61625.0921.05
Price / CashN/A33.7129.0319.80
Price / Book4.376.2211.254.90
Net Income-$6.93M$149.90M$3.47B$1.07B
7 Day Performance-2.89%0.69%2.09%-0.65%
1 Month Performance19.60%8.91%6.64%3.38%
1 Year Performance-20.27%8.07%25.02%14.90%

Milestone Scientific Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MLSS
Milestone Scientific
1.4755 of 5 stars		$0.48
+2.2%		$1.00
+108.0%		-20.3%$41.73M$9.42MN/A30
KRMD
KORU Medical Systems
3.0514 of 5 stars		$3.40
+2.1%		$7.00
+105.9%		-26.7%$156.17M$41.13MN/A80
INGN
Inogen
1.1407 of 5 stars		$5.75
-1.0%		N/A-27.6%$152.59M$354.30MN/A1,030
APYX
Apyx Medical
2.6204 of 5 stars		$3.03
-0.3%		$6.60
+117.8%		+49.3%$127.64M$52.84MN/A270
KEQU
Kewaunee Scientific
1.3782 of 5 stars		$36.51
-0.1%		N/A-35.7%$104.71M$282M11.341,231

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel